Cargando…
A Novel Seven Gene Signature-Based Prognostic Model to Predict Distant Metastasis of Lymph Node-Negative Triple-Negative Breast Cancer
BACKGROUND: The prognosis of lymph node-negative triple-negative breast cancer (TNBC) is still worse than that of other subtypes despite adjuvant chemotherapy. Reliable prognostic biomarkers are required to identify lymph node-negative TNBC patients at a high risk of distant metastasis and optimize...
Autores principales: | Peng, Wenting, Lin, Caijin, Jing, Shanshan, Su, Guanhua, Jin, Xi, Di, Genhong, Shao, Zhiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481824/ https://www.ncbi.nlm.nih.gov/pubmed/34604089 http://dx.doi.org/10.3389/fonc.2021.746763 |
Ejemplares similares
-
Nomogram for Predicting Lymph Node Involvement in Triple-Negative Breast Cancer
por: Cui, Xiang, et al.
Publicado: (2020) -
A Risk Stratification Model for Predicting Overall Survival and Surgical Benefit in Triple-Negative Breast Cancer Patients With de novo Distant Metastasis
por: Wang, Zheng, et al.
Publicado: (2020) -
A novel potential inflammation-nutrition biomarker for predicting lymph node metastasis in clinically node-negative colon cancer
por: Duan, Wanyao, et al.
Publicado: (2023) -
Immune-Activated Regional Lymph Nodes Predict Favorable Survival in Early-Stage Triple-Negative Breast Cancer
por: Chen, Yi-Yu, et al.
Publicado: (2020) -
Novel genes associated with lymph node metastasis in triple negative breast cancer
por: Mathe, Andrea, et al.
Publicado: (2015)